EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of PD‐L1 Expression in Patients With Non–Small Cell Lung Cancer Using DCE‐MRI Quantitative Analysis

Chen Yang iD, Fandong Zhu iD, Qianling Li, Chenwen Sun, Hongyan Jin, Zhenhua Zhao iD

The Clinical Respiratory Journal · 2025

DOI: 10.1111/crj.70125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2025. Verfasst von Chen Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shaoxing People's Hospital, Shaoxing, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, B7-H1 Antigen, Lung Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Laboratory of Functional Molecular Imaging of Tumor, Shaoxing People's Hospital, Shaoxing, Zhejiang, China, Zhejiang Provincial Medical and Health Research Fund Project, Shaoxing Health Science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The aim is to evaluate the expression of programmed death ligand 1 (PD‐L1) in patients with non–small cell lung cancer (NSCLC) using quantitative perfusion parameters based on dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI).

Methods

A total of 35 patients with a confirmed diagnosis of NSCLC and sufficient tissue pathology were enrolled in the study. The immunohistochemical (IHC) results were used as the gold standard to determine the thresholds for grouping the patients. The patients were divided into three categories based on their PD‐L1 expression: (1) PD‐L1‐negative (IHC < 1%) and PD‐L1‐positive (IHC ≥ 1%); (2) PD‐L1 weak (IHC < 50%) and strong expression (IHC ≥ 50%); and (3) PD‐L1 nonexpression (IHC < 1%), low expression (IHC between 1% and 49%), and high expression (IHC ≥ 50%). DCE‐MRI datasets were analyzed to acquire histogram parameters, including mean value, uniformity, skewness, kurtosis, entropy, energy, and quantity, of quantitative perfusion parameters using the extended Tofts model (ETM) and the exchange model (ECM). Subsequently, the parameters were compared between the aforementioned groups.

Results

IHC showed PD‐L1 < 1% in 20 cases, PD‐L1 (1%–49%) in 14 cases, and PD‐L1 ≥ 50% in 14 cases. At a threshold of 50%, statistically significant differences were observed for ETM/ K trans ( Q 25 and Q 50), ETM/ K ep ( Q 10), and ECM/ V e ( Q 75 and Q 90), with values being higher in the weak PD‐L1 expression group. With thresholds of 1% and 50%, the results of the pairwise comparison showed that the ECM/ V e ( Q 75) value in the low PD‐L1 expression group was significantly higher than that in the high PD‐L1 expression group.

Conclusion

DCE‐MRI quantitative analysis is a valuable tool for the evaluation of PD‐L1 expression in NSCLC. It provides a noninvasive method that can be employed as an adjunctive technique for the stratification of PD‐L1 expression in patients with NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungB7-H1 AntigenLung NeoplasmsMagnetic Resonance ImagingHumansMaleFemaleMiddle AgedAgedImmunohistochemistryContrast MediaAdultBiomarkers, TumorRetrospective StudiesDynamic Contrast Enhanced Magnetic Resonance Imaging

Stichwörter der Autor:innen

histogrammagnetic resonance imagingnon–small cell lung cancerprogrammed death ligand‐1quantitative analysis

Substanzen

B7-H1 AntigenCD274 protein, humanContrast MediaBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Radiology, Shaoxing People's Hospital, Shaoxing, China.
  • Department of Pathology, Shaoxing People's Hospital, Shaoxing, China.

ORCID-Profile: Chen Yang, Fandong Zhu, Zhenhua Zhao

Förderung

  • Key Laboratory of Functional Molecular Imaging of Tumor, Shaoxing People's Hospital, Shaoxing, Zhejiang, China
  • Zhejiang Provincial Medical and Health Research Fund Project
  • Shaoxing Health Science and Technology Plan

Zitieren

APA

Yang, C., Zhu, F., Li, Q., Sun, C., Jin, H., & Zhao, Z. (2025). Evaluation of PD‐L1 Expression in Patients With Non–Small Cell Lung Cancer Using DCE‐MRI Quantitative Analysis. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70125

Vancouver

Yang C, Zhu F, Li Q, Sun C, Jin H, Zhao Z. Evaluation of PD‐L1 Expression in Patients With Non–Small Cell Lung Cancer Using DCE‐MRI Quantitative Analysis. The Clinical Respiratory Journal. 2025. doi:10.1111/crj.70125

BibTeX
@article{Yang2025,
  author = {Yang, Chen and Zhu, Fandong and Li, Qianling and Sun, Chenwen and Jin, Hongyan and Zhao, Zhenhua},
  title = {Evaluation of PD‐L1 Expression in Patients With Non–Small Cell Lung Cancer Using DCE‐MRI Quantitative Analysis},
  journal = {The Clinical Respiratory Journal},
  year = {2025},
  doi = {10.1111/crj.70125}
}
Kostenlos starten →